After the Christmas and New Year, we continue our journey across Europe to have a glimpse of it’s vast number of Biotechs. This week, we leave Finland behind and head South-West across the Baltic Sea and back to our home town, Berlin, to visit our biotech of the week, Glycotope.
City: Berlin, Germany
Employees: 200 (as of 12/2015)
Financial Data: €135M Total Raised (as of 12/15)
Mission: Glycotope is one of the World experts in glycosylation. It has 2 major missions: the First is through the use of their technologies, GlycoExpress, to develop, optimise and produce glycosylated proteins for external sources and GlycoBody, which generates antibodies with highly specific binding to tumour cells.
Their second mission is the production of antibodies and non-antibody proteins targeting cancer and infertility, with 9 candidates currently in the pipeline. Their most promising product is FSH-GEX, a non anti-body protein targeting infertility in females,